RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 108 filers reported holding RUBIUS THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $5,450,000 | -43.1% | 989,100 | 0.0% | 0.01% | -33.3% |
| Q4 2021 | $9,574,000 | -45.9% | 989,100 | 0.0% | 0.02% | -47.1% |
| Q3 2021 | $17,685,000 | -36.9% | 989,100 | -13.9% | 0.03% | -34.6% |
| Q2 2021 | $28,029,000 | -20.0% | 1,148,255 | -13.1% | 0.05% | -23.5% |
| Q1 2021 | $35,016,000 | +668.9% | 1,321,355 | +120.2% | 0.07% | +655.6% |
| Q4 2020 | $4,554,000 | +50.6% | 600,000 | -0.6% | 0.01% | +28.6% |
| Q3 2020 | $3,024,000 | -16.2% | 603,625 | -0.0% | 0.01% | -22.2% |
| Q2 2020 | $3,610,000 | +35.2% | 603,725 | +0.6% | 0.01% | +12.5% |
| Q1 2020 | $2,670,000 | -13.5% | 600,000 | +84.6% | 0.01% | +14.3% |
| Q4 2019 | $3,088,000 | +21.1% | 325,000 | 0.0% | 0.01% | +16.7% |
| Q3 2019 | $2,551,000 | -50.1% | 325,000 | 0.0% | 0.01% | -50.0% |
| Q2 2019 | $5,112,000 | +14.4% | 325,000 | +31.6% | 0.01% | +9.1% |
| Q1 2019 | $4,469,000 | +12.5% | 246,930 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $3,971,000 | -52.7% | 246,930 | -29.4% | 0.01% | -45.0% |
| Q3 2018 | $8,400,000 | – | 350,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |